1
Trenton Nguyen, Hao Pham and Dr. Fangyuan Tian Department of Biomedical Engineering and Department of Chemistry ACKNOWLEDGEMENTS This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers; 5UL1GM118979; 5TL4GM118980; 5RL5GM118978. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Monitoring Drug Loading and Releasing in MIL-88B(Fe) Films on Modified Gold Substrates using Surface Plasmon Methods ABSTRACT Coronary Artery disease (CAD) is a major leading cause of death in the United States. Characterized by plaque narrowing the blood vessel, people with CAD have a higher chance of experiencing heart attack and stroke. Our research studies the effects of using MIL- 88B, a porous structure of the class: Metal Organic Framework (MOF) as a porous inorganic coating on drug eluting stent (DES), to prevent CAD and minimize restenosis and thrombosis effects. MIL-88B was synthesized under a solvo-thermo method and used for UV-Vis to see drug delivery properties while implementation of MIL-88B on gold was used as a model to see the binding of Ibuprofen on MIL-88B as well as the binding of 16-Mercaptohexadecanoic acid (MHDA) on gold for SPR experiments. Our results confirmed the successful preparation of ibuprofen loaded MIL-88B film on MHDA functionalized gold substrate. CONCLUSION We confirmed the encapsulation of ibuprofen within the porous MIL-88B structures by optical spectroscopic studies. The drug loading capacity of the testing Fe-MIL material was found to be about 19.5 wt% for ibuprofen delivery. SPR results showed successful binding of a MHDA SAM on clean gold surface within a few minutes. Additionally, we prepared a uniform MIL-88B film on a MHDA modified Au surface via covalent bonding. The successful encapsulation of ibuprofen in MIL-88B was confirmed by a significant change in SPR resonance response in the in situ studies. Following hexane wash, no significant decrease in SPR signal was observed for the ibuprofen-loaded MIL-88B film. This confirmed ibuprofen was encapsulated inside of MIL-88B cages not being adsorbed on the outer surface. REFERENCES 1. Novel Route to Size-Controlled FeMIL-88BNH2 MetalOrganic Framework Nanocrystals Minh-Hao Pham, Gia-Thanh Vuong, Anh-Tuan Vu, and Trong-On Do. Langmuir 2011 27 (24), 15261-15267 DOI: 10.1021/la203570h 2. Tuning Crystal Structures of Iron-Based Metal-Organic Frameworks to Control Drug Delivery Applications Pham, Hao; Ramos, Kimberly; Sua, Andy; Acuna, Jessica; Slowinska, Katarzyna; Nguyen, Trenton; Bui, Angela; Weber, Mark; Tian, Fangyuan. ACS Omega 2019, submitted RESULTS METHODS Synthesis: MIL-88B is synthesized by mixing a set amount of metal, Iron (III) Chloride with ligand, Terephthalic acid in DMF solvent. After heating for about 12 hours, a network of metal framework developed with porous centers. Surface Plasmon Resonance (SPR) SPR allows real-time, label free detection of biomolecular interactions. Self Assembled Monolayer (SAM): The formation of MHDA SAM on clean gold surface was monitored using SPR. Similarly, the binding of MIL- 88B to MHDA along with ibuprofen loading was studied using SPR. 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 245 250 255 260 265 270 275 280 285 Absorbance WaveLength (nm) Ibuprofen Absorption Ibuprofen before MIL88B Ibuprofen after MIL88B y = 0.8865x R² = 0.9983 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00 0.0 0.5 1.0 1.5 2.0 2.5 Absorbance Concentration Ibuprofen/Hexane Standard Curve Terephthalic Acid + X-ray Powder Diffraction (XRD) PXRD patterns of MIL- 88B at the condition of i) as-synthesized, ii) after solvent exchange iii) after loading with ibuprofen, in comparison to the PXRD patterns of iv) pure ibuprofen. UV-Vis Spectroscopy Infrared Spectroscopy Surface Plasmon Resonance 65 65.5 66 66.5 67 67.5 0 200 400 600 800 1000 1200 Resonance Unit (RU) Time (Seconds) Measuring Channel Reference Channel MHDA MIL-88B Ibuprofen Hexane 19.5 wt% of ibuprofen in MIL-88B = 0 Hexane Scanning Electron Microscopy ( SEM) ATR-IR spectra of a) pure ibuprofen, b) pristine Fe-MIL-88B, c) ibuprofen loaded Fe-MIL- 88B SEM images of a) clean gold b) MIL-88B crystals on MHDA-modified Au surface c) ibuprofen loaded MIL-88B crystals d) MIL-88B after releasing ibuprofen in PBS. FTIR spectra of a) Au surface, b) MHDA SAM modified Au surface, c) Fe-MIL-88B thin film on a MHDA-functionalized Au substrate, d) ibuprofen loaded Fe-MIL- 88B thin film e) Fe-MIL-88B thin film after drug releasing.

Monitoring Drug Loading and Releasing in MIL-88B(Fe) Films on … · 2020. 4. 28. · Monitoring Drug Loading and Releasing in MIL-88B(Fe) ... SPR allows real-time, label free detection

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Monitoring Drug Loading and Releasing in MIL-88B(Fe) Films on … · 2020. 4. 28. · Monitoring Drug Loading and Releasing in MIL-88B(Fe) ... SPR allows real-time, label free detection

Trenton Nguyen, Hao Pham and Dr. Fangyuan Tian

Department of Biomedical Engineering and Department of Chemistry

ACKNOWLEDGEMENTS

This research was supported by the National Institute of General Medical

Sciences of the National Institutes of Health under Award Numbers;

5UL1GM118979; 5TL4GM118980; 5RL5GM118978. The content is solely

the responsibility of the authors and does not necessarily represent the

official views of the National Institutes of Health.

Monitoring Drug Loading and Releasing in MIL-88B(Fe) Films

on Modified Gold Substrates using Surface Plasmon Methods

ABSTRACTCoronary Artery disease (CAD) is a major leading

cause of death in the United States. Characterized by

plaque narrowing the blood vessel, people with CAD

have a higher chance of experiencing heart attack and

stroke. Our research studies the effects of using MIL-

88B, a porous structure of the class: Metal Organic

Framework (MOF) as a porous inorganic coating on

drug eluting stent (DES), to prevent CAD and minimize

restenosis and thrombosis effects. MIL-88B was

synthesized under a solvo-thermo method and used for

UV-Vis to see drug delivery properties while

implementation of MIL-88B on gold was used as a

model to see the binding of Ibuprofen on MIL-88B as

well as the binding of 16-Mercaptohexadecanoic acid

(MHDA) on gold for SPR experiments. Our results

confirmed the successful preparation of ibuprofen

loaded MIL-88B film on MHDA functionalized gold

substrate.

CONCLUSIONWe confirmed the encapsulation of ibuprofen within the

porous MIL-88B structures by optical spectroscopic

studies. The drug loading capacity of the testing Fe-MIL

material was found to be about 19.5 wt% for ibuprofen

delivery. SPR results showed successful binding of a

MHDA SAM on clean gold surface within a few minutes.

Additionally, we prepared a uniform MIL-88B film on a

MHDA modified Au surface via covalent bonding. The

successful encapsulation of ibuprofen in MIL-88B was

confirmed by a significant change in SPR resonance

response in the in situ studies. Following hexane wash,

no significant decrease in SPR signal was observed for

the ibuprofen-loaded MIL-88B film. This confirmed

ibuprofen was encapsulated inside of MIL-88B cages

not being adsorbed on the outer surface.

REFERENCES

1. Novel Route to Size-Controlled Fe–MIL-88B–NH2 Metal–

Organic Framework Nanocrystals

Minh-Hao Pham, Gia-Thanh Vuong, Anh-Tuan Vu, and

Trong-On Do. Langmuir 2011 27 (24), 15261-15267 DOI:

10.1021/la203570h

2. Tuning Crystal Structures of Iron-Based Metal-Organic

Frameworks to Control Drug Delivery Applications

Pham, Hao; Ramos, Kimberly; Sua, Andy; Acuna, Jessica;

Slowinska, Katarzyna; Nguyen, Trenton; Bui, Angela;

Weber, Mark; Tian, Fangyuan. ACS Omega 2019, submitted

RESULTS

METHODSSynthesis:

MIL-88B is synthesized by mixing a set amount of

metal, Iron (III) Chloride with ligand, Terephthalic acid in

DMF solvent. After heating for about 12 hours, a

network of metal framework developed with porous

centers.

Surface Plasmon Resonance (SPR)

SPR allows real-time, label free detection of

biomolecular interactions.

Self Assembled Monolayer (SAM):

The formation of MHDA SAM on clean gold surface

was monitored using SPR. Similarly, the binding of MIL-

88B to MHDA along with ibuprofen loading was studied

using SPR.

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

245 250 255 260 265 270 275 280 285

Ab

sorb

ance

WaveLength (nm)

Ibuprofen Absorption

Ibuprofen before MIL88BIbuprofen after MIL88B

y = 0.8865xR² = 0.9983

0.000.200.400.600.801.001.201.401.601.802.00

0.0 0.5 1.0 1.5 2.0 2.5

Ab

sorb

ance

Concentration

Ibuprofen/Hexane Standard Curve

Terephthalic Acid

+

X-ray Powder Diffraction (XRD)

PXRD patterns of MIL-

88B at the condition of

i) as-synthesized,

ii) after solvent

exchange

iii) after loading with

ibuprofen, in comparison to

the PXRD patterns of

iv) pure ibuprofen.

UV-Vis Spectroscopy

Infrared Spectroscopy

Surface Plasmon Resonance

65

65.5

66

66.5

67

67.5

0 200 400 600 800 1000 1200

Res

on

ance

Un

it (

RU

)

Time (Seconds)

Measuring Channel Reference Channel

MHDA MIL-88BIbuprofen

Hexane

19.5 wt% of ibuprofen in MIL-88B

𝐿𝐶 =𝐶0 − 𝐶𝑡 ∗ 𝑉

𝑚

Hexane

Scanning

Electron

Microscopy

(SEM)

ATR-IR spectra of

a) pure ibuprofen,

b) pristine Fe-MIL-88B,

c) ibuprofen loaded Fe-MIL-

88B

SEM images of

a) clean gold

b) MIL-88B crystals

on MHDA-modified

Au surface

c) ibuprofen loaded

MIL-88B crystals

d) MIL-88B after

releasing ibuprofen

in PBS.

FTIR spectra of

a) Au surface,

b) MHDA SAM modified Au

surface,

c) Fe-MIL-88B thin film on a

MHDA-functionalized Au

substrate,

d) ibuprofen loaded Fe-MIL-

88B thin film

e) Fe-MIL-88B thin film after

drug releasing.